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Background: The initial step in establishing the cause of an effusion is to determine
whether the fluid is a transudate or exudate. Plasma viscosity is influenced by the
concentration of plasma proteins and lipoproteins with the major contribution
resulting from fibrinogen. In this study we aimed to evaluate the role of pleural fluid
viscosity in discrimination of transudate and exudates.
Materials and Methods: We studied prospectively 63 consecutive patients with
pleural effusion in whom diagnostic or therapeutic thoracentesis had been
performed. The criteria of Light were applied to differentiate transudates from
exudates: 33 patients (23 male, 13 female, mean age ¼ 68 4 years) had exudates
and 30 patients (17 male, 13 female, mean age ¼ 68 5) had transudates (due to
congestive heart failure). Measurements of pleural fluid and plasma viscosity were
performed using a viscometer.
Results: There was no statistically significant difference between patients with
transudate and exudates in respect to plasma viscosity. However, pleural viscosities
of the patients with exudates were significantly higher than those of patients with
transudate (1.3770.16mPa vs 0.9370.03mPa s po0:001, respectively). Pleural
viscosity has a high sensitivity, specificity (94%, 93%, respectively), positive and
negative predictive value (97%, 97%, respectively) for the discrimination of
transudative or exudatetive pleural fluid.
Conclusion: We have demonstrated for the first time that pleural viscosity of the
exudative effusion is higher than that of transudative effusion with high sensitivity,Elsevier Ltd. All rights reserved.
3410660.
ail.com (O. Yetkin).
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Pleural viscosity 1287specificity, positive and negative predictive value. Regarding the simplicity of this
measurement, it may play a valuable role in the accurate and fast discrimination of
pleural fluid.
& 2005 Elsevier Ltd. All rights reserved.Introduction
The development of inflammation in the pleura
results in an increased vascular permeability lead-
ing to pleural fluid accumulation. This pleural fluid
is enriched in proteins, inflammatory cells, and
mediators.1,2 Classification of pleural effusions into
transudates and exudates is based on pleural fluid
absolute lactic dehydrogenase value, fluid to serum
ratio of and fluid to serum ratio of total protein
used in a parallel combination strategy. Since
additional diagnostic or therapeutic interventions
will be tailored based on the transudative or
exudative nature of the pleural fluid, it is a crucial
diagnostic step to categorize the effusion as an
exudates or transudate.3 Multiple investigations
have examined the discriminative properties of
different pleural fluid tests for identifying exuda-
tive effusions.4,5 Established clinical practice has
favored diagnostic strategies that combine pleural
fluid lactate dehydrogenase, the ratio of pleural
fluid to serum lactate dehydrogenase, and the ratio
of pleural fluid to serum protein combined in ‘‘or’’
rules (Light’s criteria)4 wherein an exudative
effusion is identified if any one of the criteria is
fulfilled.
Plasma viscosity is influenced by the concentra-
tion of plasma proteins and lipoproteins with the
major contribution resulting from fibrinogen.6 The
physico-chemical or rheological approach states
that the contribution of individual plasma proteins
and lipoproteins to plasma viscosity depends on
their concentration, molecular weight, rigidity and
asymmetrical shape.7,8 It has been previously
reported that plasma viscosity has a valuable
importance and can be used as an acute phase
reactant.9 In this study we aimed to evaluate the
role of pleural fluid viscosity in discrimination of
transudate and exudates.Materials and methods
We studied prospectively 63 consecutive patients
with pleural effusion in whom diagnostic or
therapeutic thoracentesis had been performed.
The criteria of Light et al.4 were applied to
differentiate transudates from exudates: 33 pa-tients (23 male, 13 female, mean age ¼ 68 4
years) had exudates and 30 patients (17 male, 13
female, mean age ¼ 68 5) had transudates (due
to congestive heart failure). Exudative pleural
effusions meet at least one of Light criteria
(namely, pleural fluid/serum protein ratio, pleural
fluid/serum LDH ratio, pleural fluid LDH concentra-
tion). If none of these criteria is met, the patient
has transudative pleural effusion. Eighteen exu-
dates were considered malignant (three patients
with small extensive stage cell lung cancer, 15
patients with stage IV non-small lung cancer), since
malignant cells were detected on cytologic exam-
ination of the pleural fluid or biopsy specimens. A
pleural effusion was considered parapneumonic
ðn ¼ 12Þ when there was an acute febrile illness,
with purulent sputum and pulmonary infiltrates, in
the absence of malignancy or other diseases
causing exudate and neutrophilia in pleural fluid.
Tuberculous pleural effusion was diagnosed in two
patients by positive culture findings for Mycobac-
terium tuberculosis or a pleural biopsy specimen
showing typical epithelioid cell granulomas. After
the first successful thoracentesis of pleural fluid, a
specimen was subjected to routine biochemical
analysis including tests for total protein, glucose,
and lactate dehydrogenase. A second sample was
added to a tube containing ethylenediaminote-
traic–potassium anticoagulant for differential cell
counting. Bacterial cultures and cytologic exam-
inations were performed on all pleural effusions.
Measurements of pleural fluid and plasma viscosity
were performed using Brookfield DV-II viscometer.
One milliliter of plasma was separated by centrifu-
gation at 3000 rpm for 10min and used for plasma
viscosity measurement. Viscosity was measured in a
Brook-field DV-I1 viscometer (Brookfield, Stought-
on, MA) at shear rates of 100, 20, and 5 s21 at 37 1C.
Hospital ethic committee approved the study
protocol and all patients gave informed consent.Statistical analysis
Continuous variables are presented as mean7s.d.,
and categorical variables are presented as percen-
tage. Unpaired t-test was used to compare con-
tinuous variables between two groups. McNemar
test was used to compare categorical variables in
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O. Yetkin et al.1288dependent groups. ROC analysis was also per-
formed to find a cutoff point for differentiating
exudates and transudate. Sensitivity and specificity
of pleural viscosity were calculated by normal
procedure. A p-value less than 0.05 was considered
as statistically significant. Receiver operator char-
acteristic (ROC) analysis was carried out to deter-
mine sensitivity, specificity, positive predictive
value and negative predictive value in relation to
a number of cutoff values of pleural viscosity for
discrimination of exudate and transudate. P-values
below 0.05 were defined as statistically significant.Transudate (n=30) Exudate (n=33)
Pl
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Figure 1 Viscosity of the transudative and exudative
pleural fluid.Results
Plasma levels of albumin, and protein in patients
with transudate did not differ statistically from
those in patients with exudates (P40:05, Table 1).
However, plasma levels of lactate dehydrogenase
tended to be higher in patients with exudates
ðP ¼ 0:055Þ. Pleural fluid albumin, protein and
lactate dehydrogenase were found to be higher in
patients with exudates than in those with transu-
date as expected (Po0:001, Table 1). There was no
statistically significant difference between patients
with transudate and exudates in respect to plasma
viscosity. However, pleural viscosity of the patients
with exudates was significantly higher than that of
patients with transudate (1.3770.16mPa vs
0.9370.03mPa.s Po0:001, respectively, Table 1,
Fig. 1). The sensitivity, specificity, and predictive
values of pleural viscosity for the discrimination of
exudate or transudate in pleural effusion were
determined by ROC analysis. The area under the
ROC curve and the values for sensitivity and
specificity, as well as the positive and negative
predictive values for defined pleural viscosity cut-
off levels are displayed in Table 2. Regarding the
cutoff value of 1mPa s, pleural viscosity has a highTable 1 Characteristics of transudative and
exudative pleural fluids.
Transudate Exudate P value
Plasma albumin 3.1670.5 3.0770.18 0.29
Plasma protein 6.5670.58 6.6670.60 0.50
Plasma LDH 6277112 677783 0.055
Pleural albumin 1.1770.17 1.6570.20 o0.001
Pleural protein 2.6670.5 3.0970.27 o0.001
Pleural LDH 267752 5667160 o0.001
Plasma viscosity 1.4570.06 1.4670.05# 0.51
Pleural viscosity 0.9370.03 1.3770.16 o0.001
vs pleural viscosity Po0.001, # vs pleural viscosity
P ¼ 0:002.sensitivity, specificity (94%, 93%, respectively),
positive and negative predictive value (97%, 97%,
respectively) for the discrimination of transudative
or exudatetive pleural fluid. Sensitivity, specificity,
positive and negative predictive value of pleural
protein/plasma protein ratio, pleural lactate dehy-
drogenase/plasma lactate dehydrogenase for dis-
crimination of transudate from exudates according
to Lights’ criteria were also calculated separately
and compared to plasma viscosity (Table 3).
Positive predictive value (97%) and specificity
(93%) of the plasma viscosity were found to be
significantly higher than those of pleural protein/
plasma protein criteria (70%, 60%, respectively,
P ¼ 0:01).Discussion
There are many causes of pleural effusion, and
correct diagnosis remains a major challenge to
clinicians. The initial step in establishing the cause
of an effusion is to determine whether the fluid is a
transudate or exudate. An exudative pleural effu-
sion results from disease of the pleural surface,
while a transudative effusion results from an
imbalance of Starling’s forces resulting in move-
ment of fluid into the pleural space. Pleural fluid
formed through a normal capillary membrane is a
transudate that is characterized by little protein or
other large molecules. An exudate refers to pleural
fluid that is formed through abnormally permeable
capillary walls and contains higher concentration of
protein than do transudates.3 Established clinical
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Table 2 ROC analysis of pleural viscosity for discrimination of pleural fluid and comparison with.
Condition Cases ROC area (95% CI) Sensitivity/specificity (%) PPV/NPV
Transudate/Exudate 30/33 0.97 (0.95–1.007) 94%/93% 97%/97%
Pleural viscosity cutoff (pg/ml)o1: transudates,X1: exudates, PPV: positive predictive value, NPV: negative predictive value.
Table 3 Comparison of the sensitivity, specificity, positive and negative predictive values of pleural viscosity,
pleural protein/plasma protein, pleural LDH/plasma LDH ratio for discrimation of transudate from exudate.
Sensitivity (%) Specificity (%) PPV (%) NPV (%)
Pleural viscosity (X1mPa.s) 94 93 97 97
Pleural protein/plasma protein (40.5) 100 60 70 100
Pleural LDH/plasma LDH (40.6) 100 91 91 91
vs pleural viscosity and pleural LDH/plasma LDH ratio P ¼ 0:01, LDH: lactate dehydrogenase, PPV: positive predictive value,
NPV: negative predictive value.
Pleural viscosity 1289practice has favored diagnostic strategies that
combine pleural fluid lactate dehydrogenase, the
ratio of pleural fluid to serum lactate dehydrogen-
ase, and the ratio of pleural fluid to serum protein
combined in ‘‘or’’ rules (Light’s criteria),4 wherein
an exudative effusion is identified if any one of the
criteria is fulfilled. More recent studies have
examined the diagnostic utility of pleural fluid
cholesterol,10,11, bilirubin,5,12 and albumin12,13
concentrations comparing the sensitivities and
specificities of the new tests with the three-test
combination of Light’s criteria. Pleural fluid C
reactive protein has also been shown to be helpful
in distinguishing exudative from transudative pleur-
al fluid.14 Increased pleural levels of vascular
endothelial growth factor and matrix metallopro-
teinases is associated with exudative pleural effu-
sion suggesting increased vascular permeability and
inflammation-mediated fluid accumulation.15
The development of inflammation in the pleura
results in an increased vascular permeability lead-
ing to pleural fluid accumulation. This pleural fluid
is enriched in proteins, inflammatory cells, and
mediators.1,2 The management of pleural effusion
is still a difficult clinical problem. The fact that
plasma viscosity is also influenced by other acute-
phase proteins, like a2-macroglobulin, certain
immunoglobulins, and large lipoproteins, renders
it a biochemically composite variable. Plasma
viscosity can be measured quickly, cheaply, and
reproducibly.13 Furthermore, it shows only minimal
intraindividual variability.16
We have found that pleural viscosity of the
patients with transudative pleural effusion is
significantly lower than that of patients with
exudative pleural effusion and, pleural viscosity isa highly sensitive and specific laboratory measure-
ment in distinguishing exudative and transudative
pleural effusion with a cutoff value of 1mPa.s.
Sensitivity, specificity of the pleural viscosity are
also comparable to those of pleural LDH to plasma
LDH ratio. However, specificity and negative pre-
dictive value of pleural protein to plasma protein
ratio for the discrimination of transudate and
exudates are significantly lower than those of
plasma viscosity. Since the exudative pleural effu-
sion is mainly due to alterations in plasma
membrane and increased membrane permeability
and it contains higher concentration of proteins, it
is reasonable to expect high pleural viscosity.
However, there is no significant difference between
patients having exudative and transudative pleural
effusion in respect to plasma viscosity. Regarding
the whole circulating plasma volume in the body, it
contains lots of macro and micro molecules affect-
ing plasma viscosity. On the other hand, relatively
low volume of pleural fluid compared to plasma
volume, even small changes or accumulation of
macro or micro molecules might change the pleural
fluid viscosity where the only important factors are
pleural membrane permeability or hydrostatic
pressure. Although pleural viscosities are lower
compared to plasma viscosity in both patients
groups, the pleural viscosity of the patients having
transudative effusion is more significantly lower
compared to plasma viscosity than those of patients
having exudative effusion. This finding indirectly
also implies that the main contributing factor for
the formation of pleural fluid is the increased
hydrostatic pressure rather then the permeability
of the pleural membrane in congestive heart failure
or transudative fluids.
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O. Yetkin et al.1290In conclusion, we have demonstrated for the first
time that pleural viscosity of the exudative effusion
is higher than that of transudative effusion
with high sensitivity, specificity, positive and
negative predictive value. Regarding the simplicity
of this measurement it may play a valuable role
in the accurate and fast discrimination of pleural
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